Cargando…

A preliminary assessment of vital-signs-integrated patient-assisted intravenous opioid analgesia (VPIA) for postsurgical pain

BACKGROUND: We developed a Vital-signs-integrated Patient-assisted Intravenous opioid Analgesia (VPIA) analgesic infusion pump, a closed-loop vital signs monitoring and drug delivery system which embodied in a novel algorithm that took into account patients’ vital signs (oxygen saturation, heart rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sng, Ban Leong, Tan, Daryl Jian’an, Tan, Chin Wen, Han, Nian-Lin Reena, Sultana, Rehena, Sia, Alex Tiong Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278166/
https://www.ncbi.nlm.nih.gov/pubmed/32513113
http://dx.doi.org/10.1186/s12871-020-01060-4
_version_ 1783543278828781568
author Sng, Ban Leong
Tan, Daryl Jian’an
Tan, Chin Wen
Han, Nian-Lin Reena
Sultana, Rehena
Sia, Alex Tiong Heng
author_facet Sng, Ban Leong
Tan, Daryl Jian’an
Tan, Chin Wen
Han, Nian-Lin Reena
Sultana, Rehena
Sia, Alex Tiong Heng
author_sort Sng, Ban Leong
collection PubMed
description BACKGROUND: We developed a Vital-signs-integrated Patient-assisted Intravenous opioid Analgesia (VPIA) analgesic infusion pump, a closed-loop vital signs monitoring and drug delivery system which embodied in a novel algorithm that took into account patients’ vital signs (oxygen saturation, heart rate). The system aimed to allow responsive titration of personalized pain relief to optimize pain relief and reduce the risk of respiratory depression. Moreover, the system would be important to enable continuous monitoring of patients during delivery of opioid analgesia. METHODS: Nineteen patients who underwent elective gynecological surgery with postoperative patient controlled analgesia (PCA) with morphine were recruited. The subjects were followed up from their admission to the recovery room/ ward for at least 24 h until assessment of patient satisfaction on the VPIA analgesic infusion pump. RESULTS: The primary outcome measure of incidence of oxygen desaturation showed all patients had at least one episode of oxygen desaturation (< 95%) during the study period. Only 6 (31.6%) patients had oxygen desaturation that persisted for more than 5 min. The median percentage time spent during treatment that oxygen saturation fell below 95% was 1.9%. Fourteen (73.7%) out of 19 patients encountered safety pause, due to transient oxygen desaturation or bradycardia. The patients’ median [IQR] pain scores at rest and at movement after post-op 24 h were 0.0 [2.0] and 3.0 [2.0], respectively. The average morphine consumption in the first 24 h was 12.5 ± 7.1 mg. All patients were satisfied with their experience with the VPIA analgesic infusion pump. CONCLUSIONS: The use of VPIA analgesic infusion pump, when integrated with continuous vital signs monitor and variable lockout algorithm, was able to provide pain relief with good patient satisfaction. TRIAL REGISTRATION: This study was registered on clinicaltrials.gov registry (NCT02804022) on 28 Feb 2016.
format Online
Article
Text
id pubmed-7278166
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72781662020-06-09 A preliminary assessment of vital-signs-integrated patient-assisted intravenous opioid analgesia (VPIA) for postsurgical pain Sng, Ban Leong Tan, Daryl Jian’an Tan, Chin Wen Han, Nian-Lin Reena Sultana, Rehena Sia, Alex Tiong Heng BMC Anesthesiol Research Article BACKGROUND: We developed a Vital-signs-integrated Patient-assisted Intravenous opioid Analgesia (VPIA) analgesic infusion pump, a closed-loop vital signs monitoring and drug delivery system which embodied in a novel algorithm that took into account patients’ vital signs (oxygen saturation, heart rate). The system aimed to allow responsive titration of personalized pain relief to optimize pain relief and reduce the risk of respiratory depression. Moreover, the system would be important to enable continuous monitoring of patients during delivery of opioid analgesia. METHODS: Nineteen patients who underwent elective gynecological surgery with postoperative patient controlled analgesia (PCA) with morphine were recruited. The subjects were followed up from their admission to the recovery room/ ward for at least 24 h until assessment of patient satisfaction on the VPIA analgesic infusion pump. RESULTS: The primary outcome measure of incidence of oxygen desaturation showed all patients had at least one episode of oxygen desaturation (< 95%) during the study period. Only 6 (31.6%) patients had oxygen desaturation that persisted for more than 5 min. The median percentage time spent during treatment that oxygen saturation fell below 95% was 1.9%. Fourteen (73.7%) out of 19 patients encountered safety pause, due to transient oxygen desaturation or bradycardia. The patients’ median [IQR] pain scores at rest and at movement after post-op 24 h were 0.0 [2.0] and 3.0 [2.0], respectively. The average morphine consumption in the first 24 h was 12.5 ± 7.1 mg. All patients were satisfied with their experience with the VPIA analgesic infusion pump. CONCLUSIONS: The use of VPIA analgesic infusion pump, when integrated with continuous vital signs monitor and variable lockout algorithm, was able to provide pain relief with good patient satisfaction. TRIAL REGISTRATION: This study was registered on clinicaltrials.gov registry (NCT02804022) on 28 Feb 2016. BioMed Central 2020-06-08 /pmc/articles/PMC7278166/ /pubmed/32513113 http://dx.doi.org/10.1186/s12871-020-01060-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Sng, Ban Leong
Tan, Daryl Jian’an
Tan, Chin Wen
Han, Nian-Lin Reena
Sultana, Rehena
Sia, Alex Tiong Heng
A preliminary assessment of vital-signs-integrated patient-assisted intravenous opioid analgesia (VPIA) for postsurgical pain
title A preliminary assessment of vital-signs-integrated patient-assisted intravenous opioid analgesia (VPIA) for postsurgical pain
title_full A preliminary assessment of vital-signs-integrated patient-assisted intravenous opioid analgesia (VPIA) for postsurgical pain
title_fullStr A preliminary assessment of vital-signs-integrated patient-assisted intravenous opioid analgesia (VPIA) for postsurgical pain
title_full_unstemmed A preliminary assessment of vital-signs-integrated patient-assisted intravenous opioid analgesia (VPIA) for postsurgical pain
title_short A preliminary assessment of vital-signs-integrated patient-assisted intravenous opioid analgesia (VPIA) for postsurgical pain
title_sort preliminary assessment of vital-signs-integrated patient-assisted intravenous opioid analgesia (vpia) for postsurgical pain
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278166/
https://www.ncbi.nlm.nih.gov/pubmed/32513113
http://dx.doi.org/10.1186/s12871-020-01060-4
work_keys_str_mv AT sngbanleong apreliminaryassessmentofvitalsignsintegratedpatientassistedintravenousopioidanalgesiavpiaforpostsurgicalpain
AT tandaryljianan apreliminaryassessmentofvitalsignsintegratedpatientassistedintravenousopioidanalgesiavpiaforpostsurgicalpain
AT tanchinwen apreliminaryassessmentofvitalsignsintegratedpatientassistedintravenousopioidanalgesiavpiaforpostsurgicalpain
AT hannianlinreena apreliminaryassessmentofvitalsignsintegratedpatientassistedintravenousopioidanalgesiavpiaforpostsurgicalpain
AT sultanarehena apreliminaryassessmentofvitalsignsintegratedpatientassistedintravenousopioidanalgesiavpiaforpostsurgicalpain
AT siaalextiongheng apreliminaryassessmentofvitalsignsintegratedpatientassistedintravenousopioidanalgesiavpiaforpostsurgicalpain
AT sngbanleong preliminaryassessmentofvitalsignsintegratedpatientassistedintravenousopioidanalgesiavpiaforpostsurgicalpain
AT tandaryljianan preliminaryassessmentofvitalsignsintegratedpatientassistedintravenousopioidanalgesiavpiaforpostsurgicalpain
AT tanchinwen preliminaryassessmentofvitalsignsintegratedpatientassistedintravenousopioidanalgesiavpiaforpostsurgicalpain
AT hannianlinreena preliminaryassessmentofvitalsignsintegratedpatientassistedintravenousopioidanalgesiavpiaforpostsurgicalpain
AT sultanarehena preliminaryassessmentofvitalsignsintegratedpatientassistedintravenousopioidanalgesiavpiaforpostsurgicalpain
AT siaalextiongheng preliminaryassessmentofvitalsignsintegratedpatientassistedintravenousopioidanalgesiavpiaforpostsurgicalpain